课题基金 / 基金详情

LOW DOSE LIVER IRRADIATION WITH HEPATIC ARTERIAL CHEMOTHERAPY FOR CANCER

LOW DOSE LIVER IRRADIATION WITH HEPATIC ARTERIAL CHEMOTHERAPY FOR CANCER
低剂量肝脏照射联合肝动脉化疗治疗癌症
批准号：
6263655
负责人：
CORNELIUS J MCGINN
金额：
$0.02万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6263655
关键词：
clinical research clinical trial phase I combination therapy floxuridine human subject human therapy evaluation liver neoplasms neoplasm /cancer chemotherapy neoplasm /cancer radiation therapy radiation therapy dosage whole body irradiation dosage

项目摘要

项目成果

CORNELIUS J MCGINN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Although radiation has proven efficacy in the treatment of patients with intrahepatic cancers, its usefulness in the treatment of the whole liver is limited by the low dose that can be tolerated when radiation is delivered in conventional fraction sizes. In this phase I study, low dose per fraction irradiation (1 Gy) will be used inorder to determine if a higher total dose can be safely delivered to the whole liver. Radiation will be delivered concurrent with hepatic arterial (HA) floxuridine (FUdR).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
WHOLE LIVER RADIATION DOSE ESCALATION TRIAL UTILIZING ETHYOL AMIFOSTINE
WHOLE LIVER RADIATION DOSE ESCALATION FOR INTRAHEPATIC CANCERS
LOW DOSE LIVER IRRADIATION WITH HEPATIC ARTERIAL CHEMOTHERAPY FOR CANCER
RADIATION DOSE ESCALATION FOR FOCAL LIVER CANCER
海外基金